Alchemia (ASX:ACL) expects to be ready to announce the results of its key phase III trial of HA-Irinotecan in metastatic colorectal cancer by the end of the month.

Melbourne's Eye Co has picked up a European patent covering a new class of steroids to treat diabetic eye disease.

One decade after the Bill & Melinda Gates Foundation launched the Grand Challenges in Global Health grant program, a group of international partners has funded three new challenges aimed at creating breakthroughs in science. [ + ]

UK scientists have taken pictures of the BRCA2 protein, which is involved in DNA repair, for the first time. [ + ]

Researchers from the University of Wisconsin-Madison have developed a smartphone app that can turn Android phones into detectors to capture the light particles created when cosmic rays crash into Earth's atmosphere. [ + ]

Healthcare company CareFusion has been acquired by Becton, Dickinson and Company (BD) for $58 per share in cash and stock - a total of $12.2 billion. [ + ]

Brisbane researchers have developed a blood test that can accurately detect an allergy to Bahia grass - one of the most common causes of hay fever. [ + ]

A director with research and consulting firm GlobalData has claimed that ultrarapid formulations of the currently marketed rapid-acting insulin analogues have the potential to radically change the insulin market over the next five years. [ + ]

Analytica (ASX:ALT) has secured a CE Mark for its PeriCoach device and has launched an up to $4m capital raising to help fund marketing ahead of its formal launch in Australia. [ + ]

The East Coast Whale Watch Catalogue has collated hundreds of photographs of humpback whales along Australia's east coast - many of which have been taken by citizen scientists. [ + ]

Healthcare company Roche has announced a technology acquisition from AbVitro, a company focused on therapeutic target discovery. Roche obtained exclusive rights to a primer extension-based target enrichment (PETE) technology and associated patent applications filed by AbVitro. [ + ]

The AusBiotech Annual Report 2014 is now available, detailing how AusBiotech is delivering on its plan to facilitate global development of the Australian life sciences industry.

Bionic Vision Australia's (BVA) prototype 24-channel percutaneous connector implant was found to be safe during its first clinical trial in retinosis pigmentosa. [ + ]

AB SCIEX and Illumina have announced the OneOmics project - an exclusive partnership to bring together SWATH-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment. AB SCIEX has also announced that its Director of Reagent R&D, Dr Subhasish "Babu" Purkayastha, has been awarded the Human Proteome Organization (HUPO) Science and Technology Award. [ + ]

The Australian Genome Research Facility and the Garvan Institute of Medical Research have announced a collaboration that will help facilitate Australia's access to whole human genome sequencing.